智通财经APP讯，君实生物(01877)公布，2025 年 12 月 19 日，公司于上海证券交易所网站（www.sse.com.cn）披露了《关于持股 5%以上股东减持股份计划的公告》。因基金期限与流动性资金安排原因，上海檀英计划通过大宗交易的方式减持其持有的公司股份数量不超过 20,533,797 股，减持比例不超过公司总股本的 2%，减持期间为 2026 年 1 月 13 日至 2026 年 4 月 10 日。公司于近日收到上海檀英出具的《关于减持股份结果的告知函》，截至本公告披露日，上海檀英未减持公司股份，上述减持计划时间区间已届满。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.